Zobrazeno 1 - 10
of 105
pro vyhledávání: '"G. Caleb Alexander"'
Publikováno v:
Value Health
Objectives To estimate the effect of filgrastim-sndz market entry on patient out-of-pocket costs and claim payments for filgrastim products. Methods This study used a single interrupted time series design with longitudinal, nationally representative,
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories
Autor:
Kenneth M. Shermock, Jonathan P. Weiner, G. Caleb Alexander, H. Kan, Hadi Kharrazi, Hsien Yen Chang
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:1282-1290
Nonfilling of prescribed medications is a worldwide problem of serious concern. Studies of health care costs and utilization associated with medication nonadherence frequently rely on claims data and usually focus on patients with specific conditions
Publikováno v:
Medical Care. 57:667-672
BACKGROUND Although buprenorphine is an evidence-based treatment for opioid use disorder (OUD), it is unknown whether buprenorphine use may affect patients' adherence to treatments for chronic, unrelated conditions. OBJECTIVES To quantify the effect
Publikováno v:
JAMA Network Open
Key Points Question What are the trends in ambulatory insulin use among adults with type 2 diabetes in the United States between 2016 and 2020? Findings In this cross-sectional study of 27.9 million ambulatory insulin treatment visits, the use of ins
Autor:
Jiajun Wen, Jodi B Segal, Hsien Yen Chang, G. Caleb Alexander, Omar Mansour, Mara McAdams-DeMarco, Sheriza N. Baksh, Stephan Ehrhardt
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Clinical trials investigating cardiovascular safety of dipeptidyl peptidase-IV inhibitors (DPP-4i) among patients with cardiovascular and renal disease rarely recruit patients with renal impairment, despite associations with increased risk for major
Autor:
Brendan Saloner, Kelly E. Anderson, Julia Eckstein, G. Caleb Alexander, Sydney M. Dy, Lauren Niles, Sarah Hudson Scholle, Christine E. Chaisson
Publikováno v:
Med Care
AIMS: To characterize quality of buprenorphine care for opioid use disorder by quantifying buprenorphine initiation, engagement, and maintenance for individuals in a large, diverse, real-world cohort in the United States. DESIGN: Retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57eb2bbe06f39bc0ac13b88166fc687
https://europepmc.org/articles/PMC8026663/
https://europepmc.org/articles/PMC8026663/
Autor:
Dorry L. Segev, Krista L. Lentine, Mara McAdams-DeMarco, Matthew Daubresse, G. Caleb Alexander, Deidra C. Crews
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-1 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-1 (2021)
Individuals undergoing hemodialysis in the United States frequently report pain and receive three-fold more opioid prescriptions than the general population. While opioid use is appropriate for select patients, high-dose utilization may contribute to
Publikováno v:
American Journal of Nephrology. 49:20-31
Background: Hemodialysis (HD) patients frequently experience pain. Previous studies of HD patients suggest increased opioid prescribing through 2010. It remains unclear if this trend continued after 2010 or declined with national trends. Methods: Lon
Autor:
Hemalkumar B. Mehta, Paul G. Auwaerter, Brian T. Garibaldi, Natasha Palamuttam, Kathleen M Andersen, Daniel E. Ford, Jodi B Segal, G. Caleb Alexander
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background It is unclear whether chronic use of immunosuppressive drugs worsens or improves the severity of coronavirus disease 2019 (COVID-19), with plausible mechanisms for both. Methods Retrospective cohort study in 2121 consecutive adults with ac